EVE Health Group Limited

Equities

EVE

AU000000EVE3

Other Specialty Retailers

Market Closed - Australian S.E. 10:56:58 2024-03-27 pm EDT 5-day change 1st Jan Change
0.001 AUD 0.00% Intraday chart for EVE Health Group Limited 0.00% 0.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
EVE Health Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
EVE Health Group Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
EVE Health Group Limited Announces Retirement of Alasdair Cooke from Board as Director CI
EVE Health Group Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
EVE Health Group Limited Auditor Raises 'Going Concern' Doubt CI
Eve Health Group Limited Announces Resignation of James Lin as Director CI
Myostin Therapeutics Pty Ltd entered into a conditional Share Sale Agreement to acquire Omniblend Innovation Pty Ltd from EVE Health Group Limited and other shareholders. CI
EVE Health Group Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
EVE Health Group Announces Retirement of George Cameron-Dow from the Board CI
Eve Health Group Completes Undersubscribed Rights Offer MT
Eve Health Group Limited Appoints Rodney Hannington as Non-Executive Director CI
Eve Health Group Limited Reports Earnings Results for the Half Year Ended December 31, 2021 CI
Eve Health Group Limited announced that it has received AUD 1.4 million in funding CI
EVE Health Group Raises $1 Million for Product Expansion MT
Eve Health Group Limited announced that it expects to receive AUD 1.4 million in funding CI
Eve Health Signs Alliance Deal to Expand Australian Retail Sales MT
Eve Health Group Limited Announces Alliance Agreement CI
EVE Investments : Strikes Collaboration Deal to Develop Probiotic Product Range MT
Eve Investments' : Omni Innovation Launches New Diabetes Pre-Meal Drink; Shares Surge 33% MT
Eve Investments Limited Reports Earnings Results for the Full Year Ended June 30, 2021 CI
S&P/ASX 200 : Australian Shares End With Moderate Gains as Central Bank Keeps Rates at Record Low MT
Eve Investments : Receives First Whole Foods Market Order; Shares Surge 17% MT
Eve Investments Limited Receives US Distribution - First Whole Foods Order CI
EVE Investments Announces Board Changes CI
EVE Investments Provides an Update on Recent Activities CI
Chart EVE Health Group Limited
More charts
EVE Health Group Limited is an Australia-based vertically integrated producer of branded nutrition, health, and wellness products. The Company's segments include Jenbrook, Meluka and Investment. The Jenbrook segment produces organic tea tree and distributes Australian botanical oils. The Meluka segment is a retail health and wellness consumer brand. The Meluka segment provides retail health and wellness consumer products, including honey. The Company owns and operates the Robyndale organic tea tree plantation in the Bungawalbin Valley in Northern New South Wales. Jenbrook farm offers products, including essential oil, dried leaf, hydrosol, and extract. Its Naturally Australian Products is a wholesaler of native Australian essential oils. The Company offers various products, including Essential Oil blends, Botanical Raw Honey collection, Raw Honey Probiotic Concentrate Tea Tree, and others. It operates in markets across Australia and New Zealand, Asia Pacific, and North America.
More about the company

Chiffre d''affaires - Rate of surprise

  1. Stock
  2. Equities
  3. Stock EVE Health Group Limited - Australian S.E.
  4. News EVE Health Group Limited
  5. Eve Investments : rsquo; Meluka Australia Honey Products to Become Available in US’ Whole Foods Market